https://www.selleckchem.com/pr....oducts/s64315-mik665
9c2 cells against hypoxia-induced injury by modulating miR-25-3p/KLF4 axis in vitro. Atrial tachypacing is an accepted model for atrial fibrillation (AF) in large animals and in cellular models. Human induced pluripotent stem cells-derived cardiomyocytes (hiPSC-CM) provide a novel human source to model cardiovascular diseases. Here, we investigated whether optogenetic tachypacing of atrial-like hiPSC-CMs grown into engineered heart tissue (aEHT) can induce AF-remodeling. After differentiation of atrial-like cardiomyocytes from hiP
Curtir
Comentario
Compartilhar
